Quick clarification, for accuracy's sake: Most, but not all, of the studies of Gendicine have been published only in Chinese-language medical literature. The journal Human Gene Therapy published a study, in English, in September 2005 (available here -- click on the full text PDF link on the right for the whole thing). The study's author, Dr. Zhaohui Peng, is the head of the company that developed the drug (the former UCLA researcher mentioned above).

Another English-language study -- of Gendicine's effect on one patient with a form of liver cancer -- was published that same month in Gut, the journal of the British Society of Gastroenterology.

-- Leslie

Leslie

April 2006: Husband dx by dentist with leukoplakia on tongue. Oral surgeon's biopsy 4/28/06: Moderate dysplasia; pathology report warned of possible "skip effect." ENT's excisional biopsy (got it all) 5/31/06: SCC in situ/small bit superficially invasive. Early detection saves lives.